Related Experiment Video
Updated: Aug 5, 2025

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
Mechanisms of macular edema
Cameron D Haydinger1, Lisia Barros Ferreira1, Keryn A Williams1
1Flinders University College of Medicine and Public Health, Adelaide, SA, Australia.
Macular edema, fluid buildup in the retina, can cause vision loss. Treatments target mediators disrupting the blood-retinal barrier, but research into new therapies is ongoing.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Vascular Biology
Background:
- Macular edema involves pathological fluid accumulation in the central retina.
- It is a complication of diabetic retinopathy, retinal vascular occlusions, and uveitis.
- Dysregulation of the blood-retinal barrier leads to fluid infiltration and osmotic pressure increase.
Purpose of the Study:
- Provide a clinical overview of macular edema.
- Discuss disease mechanisms and current treatment targets.
- Identify opportunities for future research.
Main Methods:
- Review of clinical data and existing literature.
- Analysis of pathogenic mechanisms.
- Evaluation of current therapeutic strategies.
Main Results:
- Macular edema leads to decreased visual acuity and potential blindness.
- Current treatments include VEGF blockers, corticosteroids, and NSAIDs.
- These therapies target inflammatory and vasoactive mediators.
Conclusions:
- Understanding blood-retinal barrier dysregulation is key to managing macular edema.
- Targeting specific mediators offers therapeutic potential.
- Further research is needed for novel treatment approaches.
More Related Videos
10:14Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
11:20Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...